MedFactory. OHC software for Indian factories
Dangerous operation

Manufacture or manipulation of carcinogenic dye intermediates

A dangerous operation declared under Section 87 of the Factories Act 1948 — Rule 114(1) item 22 · Schedule XXII.

Rule 114(1) item 22 · Schedule XXII

Medical surveillance (statutory)

Sch XXII para 15: examined by the Medical Inspector / Certifying Surgeon within 14 days of first employment (including exfoliative urine cytology); no work beyond 14 days unless certified fit; re-examined at least once in every six calendar months (again including urine cytology); certificate of fitness in Form 23 and record in Form 7. Para 16: appointed doctor re-examines at intervals of not more than 3 months; weekly air estimation of prohibited substances; no fee to the worker.

Hazard & health effects

Agent: Carcinogenic dye intermediates (aromatic amines, e.g. benzidine, beta-naphthylamine)

Health effects: Urinary bladder carcinoma (long latency) — the basis for urine-cytology screening.

Controls & PPE

Engineering controls: Closed systems / substitution and prohibition of the most potent amines; LEV; weekly workroom air estimation; urine-cytology surveillance; decontamination.

PPE: Impervious chemical-resistant gloves/suit (skin protection critical); respiratory protection; eye protection.

Statutory vs annotation: the operation name, schedule and medical-examination clause are statutory. The hazard, health-effects, controls and PPE notes are occupational-hygiene context — verify against the gazetted schedule before acting.

This page is a statutory / occupational-health reference for factory Occupational Health Centres. It is not medical or legal advice. Verify against the current bare Act, Rules and your State amendments before acting.

MedFactorySchedule and record the statutory examinations.
Open MedFactory →